Induced pluripotent stem cells as a disease model for studying inherited arrhythmias: Promises and hurdles

Kathy O. Lui, Maxine W. Stachel, Deborah Lieu, Ronald A. Li, Lei Bu

Research output: Contribution to journalArticle

5 Scopus citations

Abstract

Cardiac ion channel mutations can lead to alterations of action potential and/or conduction properties, and consequently, arrhythmias. Although sudden cardiac death is a common manifestation of inherited arrhythmias, many aspects of the underlying mechanisms remain undefined. In addition to their potential for cell-based therapies, patient-specific induced pluripotent stem cells (iPSCs) also offer an expandable source of human cardiomyocytes for disease modeling, high-throughput drug screening and cardiotoxicity testing. Here, we review current efforts of using iPSC to model monogenetic arrhythmic diseases and discuss the associated challenges.

Original languageEnglish (US)
JournalDrug Discovery Today: Disease Models
Volume9
Issue number4
DOIs
StatePublished - Dec 2012

ASJC Scopus subject areas

  • Drug Discovery
  • Molecular Medicine

Fingerprint Dive into the research topics of 'Induced pluripotent stem cells as a disease model for studying inherited arrhythmias: Promises and hurdles'. Together they form a unique fingerprint.

  • Cite this